Search
                    Parkinson's Disease Paid Clinical Trials in New Jersey
A listing of 4  Parkinson's Disease  clinical trials  in New Jersey  actively recruiting volunteers for paid trials and research studies in various therapeutic areas.
            1 - 4 of 4
        
        
    
                The state of New Jersey currently has 4 active clinical trials seeking participants for Parkinson's Disease research studies. These trials are conducted in various cities, including New Brunswick, Hackensack, Newark and Morristown. 
            
                                Featured Trial
                
                Healthy Participants Needed (Colonoscopy + Cancer Screening)
            
        Recruiting
            
        Earn $325 - $475 in electronic payment card compensation for your time and effort by participating in a clinical study to develop a blood test that may one day help screen for colon cancer. Take a quick quiz to see if you qualify.
    
    
                            Conditions: 
                                    
        
            
                        Healthy
                    
                                    
                        Healthy Volunteers
                    
                                    
                        Healthy Subjects
                    
                                    
                        Healthy Volunteer
                    
                                    
                        Healthy Participants
                    
                                    Featured Offer
                
                Lose Weight with GLP-1 Medications
            
        Recruiting
            
        Policy Lab has partnered with OnlineSemaglutide.org to offer trusted access to semaglutide and other GLP-1 medications, including generic alternatives to Ozempic® and Wegovy®. 
GLP-1 medications are scientifically backed to help individuals achieve significant weight loss—on average, 15-20% of body weight within a year.
As a valued user, you’re eligible for $50 off your first program with code policy-lab-50.
    GLP-1 medications are scientifically backed to help individuals achieve significant weight loss—on average, 15-20% of body weight within a year.
As a valued user, you’re eligible for $50 off your first program with code policy-lab-50.
                            Conditions: 
                                    
        
            
                        Overweight
                    
                                    
                        Overweight and Obesity
                    
                                    
                        Obesity
                    
                                    
                        Weight Loss
                    
                                    
                        Morbid Obesity
                    
                                    Featured Trial
                
                Stroke Clinical Study
            
        Recruiting
            
        A clinical study for people that suffer with Stroke
    
    
                            Conditions: 
                                    
        
            
                        Stroke
                    
                                    Featured Trial
                
                Chronic Kidney Disease (CKD) Clinical Study
            
        Recruiting
            
        A clinical study for people that suffer with Chronic Kidney Disease (CKD)
    
    
                            Conditions: 
                                    
        
            
                        Chronic Kidney Disease (CKD)
                    
                                    Featured Trial
                
                Ischemic heart disease (IHD) Clinical Study
            
        Recruiting
            
        A clinical study for people that suffer with Ischemic heart disease (IHD)
    
    
                            Conditions: 
                                    
        
            
                        Ischemic heart disease (IHD)
                    
                                    Featured Trial
                
                Cardiovascular Disease Clinical Study
            
        Recruiting
            
        A clinical study for people that suffer with Cardiovascular Disease
    
    
                            Conditions: 
                                    
        
            
                        Cardiovascular Disease
                    
                                    
                
                                    To Evaluate the Efficacy of CVN424 in Parkinson's Disease Participants With Motor Complications
                                
            
            
        Recruiting
                            
            
                This is a randomized, double-blind, placebo-controlled, multicenter study in participants with Parkinson's disease (PD) with motor fluctuations. Participants will be randomized to receive once-daily oral doses of either 75 milligrams (mg) CVN424 or 150 mg CVN424, or a matching placebo for 12 weeks. Participants who successfully complete this study and retain eligibility/suitability will be invited to participate in a future open-label extension (OLE) study.             
        
        
    Gender:
                ALL
            Ages:
                30 years and above
            Trial Updated:
                07/29/2025
            
            Locations: Boro Neurology, Hopewell, New Jersey         
        
        
            Conditions: Parkinson Disease
        
            
        
    
                
                                    Virtual Cycling Environments for Persons With Parkinson Disease
                                
            
            
        Recruiting
                            
            
                This study asks three questions about Persons with Parkinson Disease that use a bicycle for exercise. 1. Does the use of virtual reality increase the intensity and and enjoyment of the experience compared to bicycling without virtual reality? 2. Does the way in which the bicycling (interval compared to continous) is performed affect the experience? 3. How does the way the virtual reality is delivered (with goggles or projected on a screen) affect the experience?             
        
        
    Gender:
                ALL
            Ages:
                Between 45 years and 75 years
            Trial Updated:
                05/20/2025
            
            Locations: School of Health Professions, Newark, New Jersey         
        
        
            Conditions: Parkinson Disease
        
            
        
    
                
                                    Parkinson's Foundation PD GENEration Genetic Registry
                                
            
            
        Recruiting
                            
            
                Development of a central repository for PD-related genomic data for future research.             
        
        
    Gender:
                ALL
            Ages:
                18 years and above
            Trial Updated:
                05/16/2025
            
            Locations: Rutgers University, New Brunswick, New Jersey         
        
        
            Conditions: Parkinson's Disease
        
            
        
    
                
                                    Investigation of Effects of Delayed Feedback on Non-motor Symptoms in Individuals With Parkinson's Disease
                                
            
            
        Recruiting
                            
            
                Learning deficits are frequent in individuals with Parkinson's Disease. Clear feedback is integral because through feedback individuals know whether they should stick with an action that they have been doing (if the feedback is positive), or change their course of action (if the feedback is negative). Learning though immediate feedback has been shown to be depended on the brain chemical dopamine that is disrupted in individuals with Parkinson's Disease. During learning, feedback can also be pres...  Read More             
        
        
    Gender:
                ALL
            Ages:
                55 years and above
            Trial Updated:
                01/19/2024
            
            Locations: Kessler Foundation, East Hanover, New Jersey         
        
        
            Conditions: Parkinson Disease
        
            
        
    1 - 4 of 4
            
            
        